Researchers evaluated mean hematocrit before and after pellet implantation in a cohort of 97 patients.
Overweight and obese men who participated in 12 weeks of aerobic exercise saw significantly increased testosterone levels, a recent study found.
Testosterone replacement therapy may not have the benefit many physicians think it does—particularly for women grappling with sexual dysfunction.
Testosterone therapy in hypogonadal men with prostate cancer who have had definitive treatment and in those on surveillance appears to be safe, according to a new study.
Urologists need to “be aware of the role and impact of [anabolic-androgenic steroid] use in our patient population,” says men’s health expert James M. Hotaling, MD, MS.
A panel of experts, including several urologists, has approved nine resolutions on what they say is evidence-based clarity on male hypogonadism and how to manage it.
A new study finds that treatment with testosterone solution 2% can be effective for hypogonadism with no new safety concerns.
The FDA has approved a new testosterone gel formulation, marking the agency’s second approval of a testosterone replacement therapy in the course of a week.
Relying on blood test results alone is insufficient for diagnosing hypogonadism, according to a recent study.
The FDA has approved testosterone undecanoate (AVEED) injection for treatment of men with hypogonadism.